Implications in the management of pregnancy: II. Low levels of gene expression but enhanced uptake and accumulation of umbilical cord glycodelin

Fertility and Sterility

Volumn 73, Issue 4, 2000, Pages 843-847

  Zhou, H Mimi ^a   Ramachandran, Sumathi ^a   Kim, Jong G ^a   Raynor, Denise B ^a   Rock, John A ^a   Parthasarathy, Sampath ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial cells; Glycodelin; Immunosuppression; Umbilical cord

Indexed keywords

PLACENTA PROTEIN 14;

ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAIN; UMBILICAL VEIN;

BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELLS, CULTURED; DECIDUA; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; GLYCOPROTEINS; HUMANS; PREGNANCY; PREGNANCY PROTEINS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UMBILICAL CORD;

EID: 0034069419     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00600-7     Document Type: Article

References (10)

1. Julkunen M., Rutanen E.M., Koskimies A., Ranta T., Bohn H., Seppala M. Distribution of placental protein 14 in tissues and body fluids during pregnancy. Br J Obstet Gynaecol. 92:1985;1145-1151.
2. Morrow D.M., Xiong N., Getty R.R., Ratajczak M.Z., Morgan D., Seppala M., et al. Hematopoietic placental protein 14. An immunosuppressive factor in cells of the megakaryocytic lineage. Am J Pathol. 145:1994;1485-1495.
3. Bolton A.E., Pockley A.G., Clough K.J., Mowles E.A., Stoker R.J., Westwood O.M., et al. Identification of placental protein 14 as an immunosuppressive factor in human reproduction. Lancet. 1:1987;593-595.
4. Okamoto N., Uchida A., Takakura K., Kariya Y., Kanzaki H., Riittinen L., et al. Suppression by human placental protein 14 of natural killer cell activity. Am J Reprod Immunol. 26:1991;137-142.
5. Pockley A.G., Barratt C.L., Bolton A.E. Placental protein 14 (PP14) content and immunosuppressive activity of human cervical mucus. Symp Soc Exp Biol. 43:1989;317-323.
6. Clark G.F., Oehninger S., Patankar M.S., Koistinen R., Dell A., Morris H.R., et al. A role for glycoconjugates in human development the human feto-embryonic defence system hypothesis. Hum Reprod. 11:1996;467-473.
7. Kim J.G., Ramachandran S., Zhou H.M., Rayner D., Parthasarathy S. Implications in the maintenance of pregnancy I. Presence of immunoreactive glycodelin in human umbilical cord vein endothelial cells. Fertil Steril. 73:2000;839-842.
8. Kim J.G., Taylor W.R., Parthasarathy S. Demonstration of the presence of lipid peroxide-modified proteins in human atherosclerotic lesions using a novel lipid peroxide-modified anti-peptide antibody. Atherosclerosis. 143:1999;335-340.
9. Seppala M., Bohn H., Tatarinov Y. Glycodelins. Tumour Biol. 19:1998;213-220.
10. Morris H.R., Dell A., Easton R.L., Panico M., Koistinen H., Koistinen R., et al. Gender-specific glycosylation of human glycodelin affects its contraceptive activity. J Biol Chem. 271:1996;32159-32167.